UB Paderborn / Katalog / Suche / in CDI

1 – 23 von 23

Sortiert nach

Antibiotic-free selection in biotherapeutics: now and forever

Pathogens, 2015-04, Vol.4 (2), p.157-181

2015

Link zum Volltext

Verfügbarkeit prüfen

Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules

Human vaccines & immunotherapeutics, 2017-04, Vol.13 (4), p.947-961

2017

Link zum Volltext

Verfügbarkeit prüfen

Codon harmonization – going beyond the speed limit for protein expression

FEBS letters, 2018-05, Vol.592 (9), p.1554-1564

2018

Link zum Volltext

Verfügbarkeit prüfen

A Chemically Defined TLR3 Agonist with Anticancer Activity

Oncoimmunology, 2023-12, Vol.12 (1), p.2227510-2227510

2023

Link zum Volltext

Verfügbarkeit prüfen

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

Journal of hepatology, 2003-12, Vol.39 (6), p.1085-1089

2003

Link zum Volltext

Verfügbarkeit prüfen

TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

Microbial cell, 2023-06, Vol.10 (6), p.117-132

2023

Link zum Volltext

Verfügbarkeit prüfen

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-1758

2004

Link zum Volltext

Verfügbarkeit prüfen

Simultaneous surface display and cargo loading of encapsulin nanocompartments and their use for rational vaccine design

Vaccine, 2018-06, Vol.36 (25), p.3622-3628

2018

Link zum Volltext

Verfügbarkeit prüfen

Effects of Pyrimidine and Purine Analog Combinations in the Duck Hepatitis B Virus Infection Model

Antimicrobial Agents and Chemotherapy, 2003-06, Vol.47 (6), p.1842-1852

2003

Link zum Volltext

Verfügbarkeit prüfen

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli

Journal of virological methods, 2016-06, Vol.232, p.8-11

2016

Link zum Volltext

Verfügbarkeit prüfen

Combination of ribosome display and next generation sequencing as a powerful method for identification of affibody binders against β-lactamase CTX-M15

New biotechnology, 2019-05, Vol.50, p.60-69

2019

Link zum Volltext

Verfügbarkeit prüfen

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-1758

2004

Link zum Volltext

Verfügbarkeit prüfen

A Chemically Defined TLR3 Agonist with Anticancer Activity

Oncoimmunology, 2023-06, Vol.12

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 2085: The specific TLR3-agonist TL-532 induces life-long anti-tumor autovaccination, cross-immunity against unrelated cancers and reverses resistance to immune checkpoint inhibitors

Cancer research (Chicago, Ill.), 2022-06, Vol.82 (12_Supplement), p.2085-2085

2022

Link zum Volltext

Verfügbarkeit prüfen

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Hepatology (Baltimore, Md.), 2004-10, Vol.40 (4), p.855-864

2004

Link zum Volltext

Verfügbarkeit prüfen

DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection

Journal of general virology, 2008-05, Vol.89 (5), p.1192-1201

2008

Link zum Volltext

Verfügbarkeit prüfen

Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants

Antiviral therapy, 2008-01, Vol.13 (3), p.381-388

2008

Link zum Volltext

Verfügbarkeit prüfen

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

Vaccine, 1999-08, Vol.17 (23), p.2983-2990

1999

Link zum Volltext

Verfügbarkeit prüfen

Development of a quantitative assay for hepatic HBV ccc DNA levels in patients with chronic hepatitis B

Journal of hepatology, 2002-04, Vol.36, p.4-4

2002

Link zum Volltext

Verfügbarkeit prüfen

Immune response to baculovirus expressed protein fragment amino acids 190–289 of respiratory syncytial virus (RSV) fusion protein

Vaccine, 1998-07, Vol.16 (11), p.1127-1130

1998

Link zum Volltext

Verfügbarkeit prüfen

A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Hepatology (Baltimore, Md.), 2004-10, Vol.40 (4), p.855-864

2004

Link zum Volltext

Verfügbarkeit prüfen

A new strategy for studying In Vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Hepatology (Baltimore, Md.), 2004-10, Vol.40 (4), p.855-864

2004

Link zum Volltext

Verfügbarkeit prüfen

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy: cccDNA levels in chronic hepatitis B patients

Gastroenterology (New York, N.Y. 1943), 2004-06, Vol.126 (7), p.1750-8

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 23 von 23

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(23)

Publikationsform

Artikel
(23)

Sprache

Englisch
(23)
Japanisch
(3)

Erscheinungsjahr

n.n

Zeitschrift / Serie

Gastroenterology
(3)
Hepatology
(3)
Vaccine
(3)
Journal Of Hepatology
(2)
Oncoimmunology
(2)
Antimicrobial Agents And Chemotherapy
(1)
Antiviral Therapy
(1)
Cancer Research
(1)
Febs Letters
(1)
Human Vaccines & Immunotherapeutics
(1)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antibiotic-free selection in biotherapeutics: now and forever

Non-conventional expression systems for the production of vaccine proteins and immunotherapeutic molecules

Codon harmonization – going beyond the speed limit for protein expression

A Chemically Defined TLR3 Agonist with Anticancer Activity

Selection of a hepatitis B virus strain resistant to adefovir in a liver transplantation patient

TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy

Simultaneous surface display and cargo loading of encapsulin nanocompartments and their use for rational vaccine design

Effects of Pyrimidine and Purine Analog Combinations in the Duck Hepatitis B Virus Infection Model

Scalable chromatography-based purification of virus-like particle carrier for epitope based influenza A vaccine produced in Escherichia coli

Combination of ribosome display and next generation sequencing as a powerful method for identification of affibody binders against β-lactamase CTX-M15

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy1

A Chemically Defined TLR3 Agonist with Anticancer Activity

Abstract 2085: The specific TLR3-agonist TL-532 induces life-long anti-tumor autovaccination, cross-immunity against unrelated cancers and reverses resistance to immune checkpoint inhibitors

A new strategy for studying in vitro the drug susceptibility of clinical isolates of human hepatitis B virus

DNA vaccination in combination or not with lamivudine treatment breaks humoral immune tolerance and enhances cccDNA clearance in the duck model of chronic hepatitis B virus infection

Suboptimal response to adefovir dipivoxil therapy for chronic hepatitis B in nucleoside-naive patients is not due to pre-existing drug-resistant mutants

Dose-dependent effects of IL-12 treatment to immune response induced after immunization with a recombinant respiratory syncytial virus (RSV) fusion protein fragment

Development of a quantitative assay for hepatic HBV ccc DNA levels in patients with chronic hepatitis B

Immune response to baculovirus expressed protein fragment amino acids 190–289 of respiratory syncytial virus (RSV) fusion protein

A new strategy for studyingin vitro the drug susceptibility of clinical isolates of human hepatitis B virus

A new strategy for studying In Vitro the drug susceptibility of clinical isolates of human hepatitis B virus

Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy: cccDNA levels in chronic hepatitis B patients

Suchergebnisse filtern